{"id":"guaiacol-carbonate","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"diguaiacyl carbonate","offLabel":[],"synonyms":["guaiacol carbonate","diguaiacyl carbonate"],"timeline":[],"approvals":[],"brandName":"Diguaiacyl Carbonate","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a orchestra, and each cell plays a specific note to create a symphony. Diguaiacyl Carbonate is like a conductor that helps the cells play the right notes at the right time to produce a healthy outcome. By interacting with specific biological pathways, it helps to restore balance and promote healing in the body.","oneSentence":"Diguaiacyl Carbonate works by interacting with specific biological pathways to produce a therapeutic effect.","technicalDetail":"Diguaiacyl Carbonate is a small molecule that likely works by binding to specific receptors or enzymes, triggering a cascade of downstream effects that ultimately lead to its therapeutic outcome."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3451","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=guaiacol%20carbonate","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=guaiacol carbonate","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:49:05.555575","biosimilars":[],"competitors":[],"genericName":"guaiacol carbonate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02642874","phase":"PHASE3","title":"Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2017-04-01","conditions":["Liver Cirrhosis"],"enrollment":200,"completionDate":"2020-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"MMSL":"12074","NDDF":"003178","UNII":"Q71XPQ6R29","CHEBI":"CHEBI:135131","VANDF":"4020199","RXNORM":"5031","UMLSCUI":"C0771805","ChEMBL_ID":"CHEMBL1898058","DRUGBANK_ID":"DB11359","PDB_CHEM_ID":" JZ3","PUBCHEM_CID":"11104","SNOMEDCT_US":"424656002","MESH_DESCRIPTOR_UI":"D006139"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Diguaiacyl Carbonate, also known as guaiacol carbonate, is a small molecule modality with unknown target and drug class. Its commercial status is currently unknown, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is not well understood. Further research is needed to determine its potential therapeutic applications and safety profile. The development and ownership of this compound are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}